India Globalization Capital, Inc. (IGC)

igcIndia Globalization Capital, Inc operates in several locations around the world to acquire, incubate, finance, and grow companies in various industries. Through its subsidiaries, it has businesses in India, Inner Mongolia, China, Hong Kong, and the United States. Its business lines include iron ore processing, electronic components trading, clean energy, equipment leasing, and vertical farming, and it has entered the marijuana industry as well.

The company’s foray into the legal cannabis industry involves its vertical farming projects in the US. Currently, it is planning to build indoor vertical farms designed to produce organic green vegetables, and eventually, legal marijuana. Also part of the company’s strategy are creating a portfolio of cannabis and hemp-based patents, developing FDA-approved drugs based on cannabinoids, and establishing a cannabis R&D laboratory.

More recently, the multi-national company acquired Midtown Partners & Co, LLC, a New York-based licensed broker-dealer, to expand its marijuana strategy. With Midtown as its subsidiary, IGC will offer capital-raising platforms and broker-dealer services to cannabis businesses. One of the major platforms it plans to build is a crowdfunding site for small to midsize enterprises. Other services will include investment banking and equity research.

The legal marijuana industry is only one of the areas where IGC intends to expand. To minimize its dependence on its iron ore business, its diversification strategy aims for growth in clean technology, solar energy, and specialty pharmaceuticals as well.

India Globalization Capital was incorporated in Maryland in 2005. It now trades in the NYSE MKT with the symbol IGC, and a market cap of USD 8.69 M.

Among the top management executives in the company are Ram Mukunda, CEO, President, and Director; Daniel Ngai, Principal Financial and Accounting Officer; and Belur Ram Kishan, Sunny Tsang, and Amit Dutta, Managing Directors.

Yahoo! Finance: IGC News

Latest Financial News for IGC

Money flows in 17 popular marijuana stocks show fewer ‘short squeezes’

Prior low-level convictions for marijuana possession will be pardoned. Amid this news, one would expect marijuana stocks to run higher, but that’s not happening. Just like a doctor does X-rays to see what is going on inside the human body, investors can do an X-ray of marijuana stocks to figure out what is really going on.

IGC Reports Financial Results for the Fiscal Year Ended March 31, 2019

India Globalization Capital, Inc. announces its financial results for the Fiscal Year Ended March 31, 2019.

India Globalization Capital Subsidiary Secures Hemp Cultivation, Harvesting License In Arizona

Holi Hemp, a subsidiary of India Globalization Capital, Inc. (NYSE: IGC ), said Thursday that its application for the cultivation and harvesting of hemp was approved by Arizona’s Department of Agriculture ...

IGC to Participate in Arizona’s Industrial Hemp Program

India Globalization Capital, Inc. (IGC) announces that its subsidiary Holi Hemp’s application has been approved and that it has executed agreements with operators to grow and harvest industrial hemp under the terms and conditions of the Industrial Hemp Program developed by the Arizona Department of Agriculture (AZDA). Our strategy is to ensure the highest quality output by controlling the production of important cannabinoids like Cannabidiol (CBD) and Cannabigerol (CBG) among others, both as a supplier and to support our products such as HyalolexTM and Holi HempTM. “We selected Arizona after much analysis including assessing climate, cost of labor, political environment, local support, logistics, market penetration, and competition, among other factors.

Robbins Arroyo LLP: India Globalization Capital, Inc. (IGC) Sued for Misleading Investors

Shareholder rights law firm Robbins Arroyo LLP announces that a purchaser of India Globalization Capital, Inc. (IGC) has filed a derivative complaint against the company's officers and directors for breaches of fiduciary duty from October 25, 2017 through the present. India Globalization develops and commercializes cannabis-based therapies.